Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia

Brain

Volumn 124, Issue 1, 2001, Pages 20-29

  Heiss, Wolf Dieter ^a,b   Kracht, Lutz W ^a   Thiel, Alexander ^a   Grond, Martin ^a   Pawlik, Gunter ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

CBF; Flumazenil; Ischaemic stroke; Outcome prediction; Probability thresholds

Indexed keywords

FLUMAZENIL;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN NECROSIS; BRAIN PERFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG EFFICACY; FEMALE; HUMAN; MALE; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PRIORITY JOURNAL; REPERFUSION; STROKE; WHITE MATTER;

EID: 0035186833     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/124.1.20     Document Type: Article

References (56)

1. In vivo studies of the central benzodiazepine receptors in the human brain with positron emission tomography
2. PET studies in acute stroke: Findings and relevance to therapy
3. Thresholds in cerebral ischemia - The ischemic penumbra
4. Magnetic resonance imaging of acute stroke
5. Stroke-damaged neurons may commit cellular suicide
6. Mapping the ischaemic penumbra with PET: Implications for acute stroke treatment
7. Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: A positron tomography study
8. Diagnosis of acute cerebral infarction: Comparison of CT and MR imaging
9. Role of oxidants in ischemic brain damage
10. Antagonizing excitotoxicity: A therapeutic strategy for stroke?
11. Anti-adhesion molecule and nitric oxide protection strategies in ischemic stroke
12. Clinical trials with neuroprotective drags in acute ischaemic stroke: Are we doing the right thing?
13. The role of inflammation after acute stroke. Utility of pursuing anti-adhesion molecule therapy
14. Pathobiology of ischaemic stroke: An integrated view
15. Recently developed neuroprotective therapies for acute stroke: A qualitative systematic review of clinical trials
16. Automated blood sampling systems for positron emission tomography
17. Computed tomography findings in the first few hours of ischemic stroke: Implications for the clinician
18. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain
19. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra
20. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial
21. Pathophysiological consequences of white matter as compared to gray matter ischemia
22. Early computed-tomography abnormalities in acute stroke
23. Early X-ray hypoattenuation of brain parenchyma indicates extended critical hypoperfusion in acute stroke
24. The current status of neuronal protective therapy: Why have all neuronal protective drugs worked in animals but none so far in stroke patients?
25. Early CT changes of ischemia: Limitations of what we know
26. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study ECASS
27. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
28. The effect of nimodipine on the evolution of human cerebral infarction studied by PET
29. Functional recovery of cortical neurons as related to degree and duration of ischemia
30. Progressive derangement of periinfarct viable tissue in ischemic stroke
31. Positron emission tomography imaging and the therapeutic window
32. Early detection of irreversibly damaged ischemic tissue by flumazenil positron emission tomography in cats
33. 2O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy
34. Brain blood flow measured with intravenous H2(15)O. 1. Theory and error analysis
35. Diffusion MRI in patients with transient ischemic attacks
36. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging
37. Does neuroprotection improve stroke outcome?
38. 15O]water and PET without arterial blood sampling
39. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke. A correlative PET-CT study with voxel-based data analysis
40. Voxel-based mapping of irreversible ischaemic damage with PET in acute stroke
41. Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI
42. Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography
43. Tissue plasminogen activator for acute ischemic stroke
44. An interactive technique for three-dimensional image registration: Validation for PET, SPECT, MRI and CT brain studies
45. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans
46. The effect of hemodynamically significant carotid artery disease on the hemodynamic status of the cerebral circulation
47. Caspases as treatment targets in stroke and neurodegenerative diseases
48. Cellular regulation of the benzodiazepine/GABA receptor: Arachidonic acid, calcium, and cerebral ischemia
49. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon
50. Eine Methode zur oberflächenbezogenen Quantifizierung funktioneller Daten am Beispiel des menschlichen Kortex
51. Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosis
52. Acute stroke: Usefulness of early CT findings before thrombolytic therapy
53. Pitfalls and potential of clinical diffusion-weighted MR imaging in acute stroke
54. The ECAT EXACT HR: Performance of a new high resolution positron scanner
55. Serial observations on the pathophysiology of acute stroke
56. MR imaging of cerebral ischemia: Findings in the first 24 hours